-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - Version 1.0 September 2017
Disclaimer
The findings and conclusions in this document are those of the author … Using This Artifact ............................................................................ 2
Description … Implementing and Using This Artifact
Description and Purpose of the Artifact
This artifact provides … Table 1: Artifact Manifest
Filename Purpose Author(s)
Million_Hearts_Baseli CQL representation of … ASCVD Risk 8
Version 1.0 September 2017
Filename Purpose Author(s)
Million_Hearts_Baseli
ne_10_
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
December 01, 2018 - The findings and conclusions in this document are those of the author … This was a “lessons learned” from
the pilot partnership last year with
a health center affiliate … Implementation Decision: Change
code to specify a 1-year lookback. … Application for new terminology codes (at least using the LOINC terminology), requires IP
approval from the author … LOINC representatives are willing to assist with
author engagement to facilitate approval.
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - ........................................................................................ 3
Artifact Description … Implementing and Using This Artifact
Artifact Description
The Aspirin Therapy artifact helps clinicians … Patient has less than a 10-year life expectancy.
h. … can use the
open-source Clinical Quality Language Visual Studio Code extension to more efficiently
author … Contents
Figures
Tables
Background
Introduction
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
January 01, 2024 - ........................................................................................ 3
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact provides statin therapy recommendations … would be 75 – 76 during the current calendar year. … Implementation
guidance
Clarify difference
between eCQM
narrative and eCQM
logic
The narrative description … Contents
Figures
Tables
Background
Introduction
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - ....................................................................................... 9
Artifact Description … Implementing and Using This Artifact
Artifact Description
This CDS artifact provides the ability … cql-execution
https://github.com/DBCG/cql_engine
15
Table 1: Artifact Manifest
Filename Purpose Author … Rute Martins, Chris
Moesel, Sharon
Sebastian
16
Filename Purpose Author(s)
CDS_Connect_Conve … Purpose, and Audience of This Implementation Guide
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April … ........................................................................................ 9
Artifact Description … Implementing and Using This Artifact
Artifact Description
The Updated ASCVD Risk artifact extends … Calculation of a baseline 10-Year ASCVD risk assessment score.
2. … Purpose, and Audience of This Implementation Guide
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Slides_August%202021.pdf
August 01, 2021 - 15
Testing FAIRness: Example
Example: A FAIR guiding principle applied to develop a criterion,
description … of the criterion, and scoring element
Criteria # Criteria Description Scoring
F1.1.1
Artifacts have … in progress):
− CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - Updated10-
year ASCVD risk score calculation to use either of two ACC-
endorsed risk scores. … ........................................................................................ 4
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact identifies adults aged 40 … risk of CVD events.2 The ACC/AHA PCE calculates the 10-year risk of an atherosclerotic
CVD (ASCVD) … Tables
Background
Introduction
Scope and Purpose
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - Updated10-
year ASCVD risk score calculation to use either of two ACC-
endorsed risk scores. … ........................................................................................ 4
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact identifies adults aged 40 … risk of CVD events.”2 The ACC/AHA PCE calculates the 10-year risk of
an atherosclerotic CVD (ASCVD) … Tables
Background
Introduction
Scope and Purpose
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - ........................................................................................ 4
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact identifies adults aged 40 … risk of CVD events.”2 The ACC/AHA PCE calculates the 10-year risk of an atherosclerotic
CVD (ASCVD) … The second
difference is the recommendation for offering a statin when the 10-year CVD risk is 7.5% … Tables
Background
Introduction
Scope and Purpose
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - ........................................................................................ 9
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact extends the use of the CMS … Calculation of a baseline 10-Year ASCVD risk assessment score.
2. … “10-year risk” Risk of showing evidence of ASCVD within the next 10 years. … Purpose, and Audience of This Implementation Guide
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
January 01, 2024 - ........................................................................................ 4
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact identifies adult patients … The author of the CQL may not proceed to writing or
updating the next portion of the code until all … Inclusions “estimated 10-year
ASCVD risk of 7.5%
or greater”
The estimated 10-year ASCVD risk score … Tables
Background
Introduction
Scope and Purpose
Implementing and Using This Artifact
Artifact Description
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - Then for each field, the definition includes
characteristics such as the title or caption,
the description … For example,
an author can choose a code-based
property and indicate a set of codes it
should match … As another example,
an author could choose a quantity-based
property and indicate a range it should … In Figure 5, an author has defined
a query representing the following:
CDS Connect Maintenance … For each link, the author
must provide a label, a type (“absolute”
or “smart”), and a URL.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - ........................................................................................ 4
Artifact Description … glucose level consistent with
prediabetes.
4
Implementing and Using This Artifact
Artifact Description … Bravo is a 22-year-old overweight Hispanic woman with a family history of
diabetes. … The author of the CQL may not proceed to writing or updating the next portion
of the code until all … • Synthetic patient included because they are a 28-year-old Asian female with a BMI of 23
kg/m2.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - ........................................................................................ 4
Artifact Description … Implementing and Using This Artifact
Artifact Description
This artifact identifies patients in relevant … Bravo is a 28-year-old woman who developed gestational diabetes during her last
pregnancy. … Individuals who had behavioral counseling for nutrition and/or activity within the
past year. … The author of the CQL may not proceed to writing or updating the next portion
of the code until all
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1
Background 1
Audience, Purpose, and Scope of this IG 1
Implementing and Using This Artifact 2
Description … Implementing and Using This Artifact
Description and Purpose of the Artifact
This artifact provides the … Calculation of a baseline 10-Year ASCVD risk assessment score.
2. … "10-year... risk"
Risk of showing evidence of ASCVD within the next 10 years.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Implementing and Using This Artifact
Description and Purpose of the Artifact
This artifact allows … The author
of the CQL may not proceed to writing or updating the next portion of the code until all … In 2024, the artifact
author elected to remove ICD-9 codes (which had been used to capture historic … The lookback period is expressed as one year to align with
the recommendation. … The CQL queries for the result
of all assessments completed in the past year.
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
October 01, 2017 - Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1
Background 1
Audience, Purpose, and Scope of this IG 1
Implementing and Using This Artifact 2
Description … Implementing and Using This Artifact
Description and Purpose of the Artifact
This artifact helps providers … Data-driven screening, when a new 10-year ASCVD risk score is documented
Ms. … Patient has less than 10-year life expectancy.
h.
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - Disclaimer
The findings and conclusions in this document are those of the author(s), who are responsible … Introduction 1
Background 1
Audience, Purpose, and Scope of this IG 1
Implementing and Using This Artifact 2
Description … Implementing and Using This Artifact
Description and Purpose of the Artifact
This artifact extends the … artifact “Longitudinal ASCVD Tool for Baseline 10-Year ASCVD Risk.” … Calculation of a baseline 10-Year ASCVD risk assessment score.
2.
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
October 01, 2017 - Version 1.0 September 2017
Disclaimer
The findings and conclusions in this document are those of the author … Introduction 1
Background 1
Audience, Purpose, and Scope of this IG 1
Implementing and Using This Artifact 2
Description … Implementing and Using This Artifact
Description and Purpose of the artifact
This artifact provides statin … Table 1: Artifact Manifest
Filename
Purpose
Author(s)
Statin_Therapy_for_the_Prevention_and_Treatment_of_CVD_eCQM_Derived_FHIRv102 … would be 75-76 during the current calendar year.